Advertisement

A New Synthesis of (+)-Negamycin and Its Derivatives as a Potential Therapeutic Agent for Duchenne Muscular Dystrophy Treatment

  • Yoshio Hayashi
  • Shigenobu Nishiguchi
  • Magne O. Sydnes
  • Thomas Regnier
  • Jun-ya Hasegawa
  • Takahiro Katoh
  • Tetsuya Kajimoto
  • Manabu Node
  • Yoshiaki Kiso
Part of the Advances in Experimental Medicine and Biology book series (volume 611)

Keywords

Duchenne Muscular Dystrophy Duchenne Muscular Dystrophy Total Synthesis Aminoglycoside Antibiotic Potential Therapeutic Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Kondo, S., Shibahara, S., Takahashi, S., Maeda, K., Umezawa, H., and Ohno, M. J. Am. Chem. Soc., 93, 6305–6306 (1971).CrossRefGoogle Scholar
  2. 2.
    Uehara, Y., Kondo, S., Umezawa, H., Suzukake, K., Hori, M. J. Antibiot., 25, 685–688 (1972).CrossRefGoogle Scholar
  3. 3.
    Nishide, K., Ozeki, M., Kunishige, H., Shigeta, Y., Patra, P. K., Hagimoto, Y., Node M. Angew. Chem. Int. Ed. 42, 4515–4517 (2003).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Yoshio Hayashi
    • 1
    • 2
  • Shigenobu Nishiguchi
    • 1
  • Magne O. Sydnes
    • 1
  • Thomas Regnier
    • 1
  • Jun-ya Hasegawa
    • 3
  • Takahiro Katoh
    • 3
  • Tetsuya Kajimoto
    • 3
  • Manabu Node
    • 3
  • Yoshiaki Kiso
    • 1
  1. 1.Department of Medicinal ChemistryKyoto Pharmaceutical UniversityKyotoJapan
  2. 2.Department of Medicinal ChemistrySchool of Pharmacy, Tokyo University of Pharmacy and Life SciencesHachioji, TokyoJapan
  3. 3.Department of Pharmaceutical Manufacturing ChemistryKyoto Pharmaceutical UniversityKyotoJapan

Personalised recommendations